USANA Health Sciences Inc (USNA)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 80.95% | 80.65% | 80.55% | 80.76% | 80.56% | 80.27% | 80.25% | 80.14% | 80.32% | 80.47% | 80.82% | 81.36% | 81.38% | 81.36% | 81.33% | 80.96% | 81.35% | 81.98% | 82.14% | 82.20% |
| Operating profit margin | 7.74% | 9.53% | 9.61% | 10.07% | 10.07% | 9.82% | 10.14% | 10.38% | 10.74% | 11.19% | 12.44% | 13.77% | 14.30% | 15.48% | 15.56% | 15.40% | 15.51% | 15.38% | 15.00% | 14.24% |
| Pretax margin | 8.91% | 10.71% | 10.76% | 11.19% | 11.09% | 10.60% | 10.66% | 10.63% | 10.84% | 11.28% | 12.43% | 13.82% | 14.34% | 15.66% | 15.69% | 15.52% | 15.64% | 15.45% | 15.21% | 14.54% |
| Net profit margin | 4.91% | 6.29% | 6.28% | 6.86% | 6.90% | 6.43% | 6.67% | 6.68% | 6.92% | 7.38% | 8.25% | 9.38% | 9.79% | 10.99% | 11.04% | 10.91% | 10.96% | 10.57% | 10.36% | 9.76% |
The profitability ratios of USANA Health Sciences Inc over the specified time period show a general trend of declining margins.
- Gross Profit Margin has decreased from 82.20% on March 31, 2020, to 80.95% on December 31, 2024. This indicates a potential decrease in the company's ability to generate profits after accounting for the cost of goods sold.
- Operating Profit Margin has also exhibited a declining trend, falling from 15.00% on June 30, 2020, to 7.74% on December 31, 2024. This suggests a decrease in the company's efficiency in controlling operating expenses relative to its revenues.
- Pretax Margin has followed a similar downward trajectory, declining from 15.21% on June 30, 2020, to 8.91% on December 31, 2024. This indicates a reduction in the company's profitability before accounting for taxes.
- Net Profit Margin has shown a consistent decrease from 10.36% on June 30, 2020, to 4.91% on December 31, 2024. This decline in net profit margin indicates a decrease in USANA Health Sciences Inc's profitability after all expenses, including taxes, have been taken into account.
Overall, the declining trend in profitability margins suggests potential challenges in maintaining efficient cost control, generating revenues, and managing overall profitability for USANA Health Sciences Inc during the specified period.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 8.86% | 12.26% | 13.36% | 14.45% | 14.71% | 15.20% | 16.00% | 16.74% | 18.04% | 20.96% | 24.14% | 27.76% | 29.46% | 33.03% | 33.11% | 31.08% | 27.54% | 29.18% | 30.97% | 31.70% |
| Return on assets (ROA) | 5.62% | 8.09% | 8.72% | 9.84% | 10.08% | 9.95% | 10.52% | 10.78% | 11.63% | 13.82% | 16.00% | 18.91% | 20.17% | 23.46% | 23.50% | 22.02% | 19.45% | 20.05% | 21.38% | 21.72% |
| Return on total capital | 12.93% | 16.39% | 18.03% | 20.27% | 20.66% | 21.00% | 21.64% | 22.85% | 25.04% | 28.62% | 33.38% | 40.95% | 43.20% | 48.23% | 47.24% | 45.59% | 40.41% | 43.91% | 46.15% | 48.31% |
| Return on equity (ROE) | 7.90% | 10.19% | 10.75% | 12.39% | 12.83% | 12.72% | 13.52% | 14.33% | 15.96% | 18.70% | 22.12% | 27.79% | 29.49% | 34.03% | 33.20% | 31.96% | 28.23% | 29.76% | 31.37% | 32.40% |
USANA Health Sciences Inc's profitability ratios have shown a declining trend over the analyzed periods.
1. Operating return on assets (Operating ROA) has gradually decreased from 31.70% as of March 31, 2020, to 8.86% by December 31, 2024. This indicates a diminishing ability of the company to generate profits from its operational assets over time.
2. Return on assets (ROA) also followed a similar pattern, declining from 21.72% in March 31, 2020, to 5.62% by December 31, 2024. It suggests that the company's overall asset efficiency in generating earnings has weakened.
3. Return on total capital has also exhibited a decreasing trend, dropping from 48.31% in March 31, 2020, to 12.93% by December 31, 2024. This indicates a declining profitability concerning the total capital employed by the company.
4. Return on equity (ROE) decreased from 32.40% in March 31, 2020, to 7.90% by December 31, 2024, signalling a declining return for the equity holders over the period.
Overall, the declining profitability ratios of USANA Health Sciences Inc suggest challenges in generating profits from its assets and capital, which may warrant further analysis into the company's operational efficiency and financial management strategies.